Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,120.23
(
0.80%
)
US TECH 100
26,098.00
(
1.26%
)
Dow Jones
49,489.62
(
0.09%
)
Brent Oil
97.15
(
2.25%
)
Bitcoin
79,204.74
(
3.77%
)
News Focus
News Focus

Replies to post #188413 on Biotech Values

Replies to #188413 on Biotech Values
icon url

DewDiligence

03/10/15 3:00 PM

#188414 RE: dewophile #188413

Jay Luly said today that a competitive HCV regimen must include an NS5A inhibitor.